doi: 10.1016/j.maturitas.2018.03.004 [DOI] [PubMed] [Google Scholar] 214
Multilingual Access and Digital Edition The 2025 Prohibited List, along with the Summary of Modifications and Monitoring Program, is available in English, French, and Spanish
Clinical research demonstrated that AOD-9604 does not elevate IGF-1 levels, which distinguishes it from other fat loss peptides
Research-grade BPC-157 is sold as a laboratory chemical with no COA verification, frequently contains impurities, is often incorrectly dosed, and is not produced under any pharmaceutical quality standard
The Bottom Line: Compelling Mechanisms Demand Rigorous Human Investigation BPC-157 presents a fascinating scientific paradox: extensive preclinical evidence spanning three decades demonstrates pleiotropic effects across multiple neurotransmitter systems, with antidepressant efficacy exceeding standard drugs in animal models, anxiolytic effects without dependence liability, neuroprotection in stroke and neurodegeneration models, and reversal of schizophrenia-like cognitive deficits
The resonance form with a nitrogen-carbon double bond is thus more significant than the corresponding resonance form for esters
